8.40
price up icon4.35%   0.35
after-market Handel nachbörslich: 8.41 0.010 +0.12%
loading

Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten

pulisher
Jun 16, 2025

Champions Oncology: Biological IP Is The Real AssetNot Preclinical Services - Seeking Alpha

Jun 16, 2025
pulisher
Jun 14, 2025

Champions Oncology, Inc.'s (NASDAQ:CSBR) 11% gain last week benefited both private equity firms who own 30% as well as insiders - Yahoo Finance

Jun 14, 2025
pulisher
Jun 13, 2025

After A Standout Q3, What's On The Horizon For Champions Oncology? - RTTNews

Jun 13, 2025
pulisher
Jun 11, 2025

"STRONGER TOGETHER": SWITZERLAND CHAMPIONS INTERNATIONAL PARTNERSHIPS AS KEY TO ACCELERATED INNOVATION", ONCE AGAIN SWITZERLAND IS SHOWCASING ITS BIOTECH EXCELLENCE AT BIO INTERNATIONAL IN BOSTON 1 - Yahoo

Jun 11, 2025
pulisher
Jun 10, 2025

How To Trade (CSBR) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 05, 2025

Humanized Mouse and Rat Model Market worth US$409.8 million - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR | MarketsandMarkets™ - Barchart.com

Jun 05, 2025
pulisher
May 29, 2025

(CSBR) Long Term Investment Analysis - news.stocktradersdaily.com

May 29, 2025
pulisher
May 20, 2025

Positive Sentiment Still Eludes Champions Oncology, Inc. (NASDAQ:CSBR) Following 26% Share Price Slump - simplywall.st

May 20, 2025
pulisher
May 16, 2025

Sixth Annual Champions Gala Raises Money for Lehigh Valley Topper Cancer Institute - Lehigh Valley Health Network

May 16, 2025
pulisher
May 14, 2025

Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO) - Seeking Alpha

May 14, 2025
pulisher
May 14, 2025

Leading Oncologist Wins ASCO's Top Advocacy Award for Fighting Cancer Care Barriers - Stock Titan

May 14, 2025
pulisher
May 08, 2025

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Where are the Opportunities in (CSBR) - news.stocktradersdaily.com

May 08, 2025
pulisher
Apr 28, 2025

Champions Oncology Says It Has Obtained License to Use Radioactive Materials in Preclinical Studies - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

CSBR Secures License for Radioactive Material Use in Preclinical Studies | CSBR Stock News - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House - Bellingham Herald

Apr 28, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 28, 2025

Champions Oncology Unlocks Next-Gen Cancer Treatment Capabilities with Strategic Radiotherapy License - Stock Titan

Apr 28, 2025
pulisher
Apr 27, 2025

Champions Oncology Reports Record Quarterly Revenue of $9.5 Million - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

Champions Oncology Reports Quarterly Revenue of $12.9 Million - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 26, 2025

Champions Oncology Reports Quarterly Revenue of $12.0 Million - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 24, 2025

Champions Oncology (CSBR) Partners with Turbine to Boost Drug Di - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Turbine Launches the World’s First Virtual Lab Using Cell Simulations - Business Wire

Apr 24, 2025
pulisher
Apr 23, 2025

Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR | MarketsandMarkets - The Malaysian Reserve

Apr 23, 2025
pulisher
Apr 13, 2025

Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their respectable 47% return over the last year - Yahoo

Apr 13, 2025
pulisher
Apr 11, 2025

I-Apollo Hospitals, yethula i-“Cancer Champions United” isinyathelo esiyingqayizivele sokunikeza amandla Abasinde Ngomdlavuza! - Apollo Hospitals

Apr 11, 2025
pulisher
Apr 08, 2025

Patient Derived Xenograft Model Market Future Business - openPR.com

Apr 08, 2025
pulisher
Apr 05, 2025

Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 - ACCESS Newswire

Apr 05, 2025
pulisher
Apr 05, 2025

Investors Give Champions Oncology, Inc. (NASDAQ:CSBR) Shares A 28% Hiding - simplywall.st

Apr 05, 2025
pulisher
Apr 03, 2025

American Battery Technology boosts recycled battery output - Investing.com

Apr 03, 2025
pulisher
Mar 28, 2025

Apollo Hospitals, yakhazikitsa "Cancer Champions United" njira yapadera yopatsa mphamvu Opulumuka Khansa! - Apollo Hospitals

Mar 28, 2025
pulisher
Mar 26, 2025

Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews

Mar 26, 2025
pulisher
Mar 17, 2025

CHAMPIONS ONCOLOGY, INC. SEC 10-Q Report - TradingView

Mar 17, 2025
pulisher
Mar 13, 2025

Champions Oncology Third Quarter 2025 Earnings: EPS: US$0.33 (vs US$0.19 loss in 3Q 2024) - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

Champions Oncology target raised to $12 at Craig-Hallum By Investing.com - Investing.com Canada

Mar 13, 2025
pulisher
Mar 13, 2025

Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Call Transcript - MSN

Mar 13, 2025
pulisher
Mar 12, 2025

Earnings call transcript: Champions Oncology Q1 2025 earnings beat expectations By Investing.com - Investing.com South Africa

Mar 12, 2025
$21.56
price down icon 2.13%
$34.91
price up icon 1.01%
$20.16
price up icon 1.56%
$99.46
price down icon 0.82%
$104.40
price down icon 0.54%
biotechnology ONC
$252.78
price down icon 0.52%
Kapitalisierung:     |  Volumen (24h):